Danazol in the management of ureteral obstruction secondary to endometriosis.
Ureteral obstruction caused by endometriosis is uncommon. It is, however, an important complication that imposes a 25% chance for permanent loss of renal function on the affected side. The standard management is surgical; however, three cases have been reported in which regression of obstruction followed medical therapy. This case report concerns a patient with long-standing partial ureteric obstruction due to endometriosis who was treated for 2 months with danazol. Clinical response of the endometriosis was excellent, but the obstruction persisted, a retroperitoneal ureteroneocystotomy was therefore performed. The ureter was found to be obstructed by dense fibrous tissue that contained endometrial glands. It seems therefore that a trial of danazol may be attempted in selected cases, but that the drug is unlikely to relieve endometriotic ureteric obstruction once dense fibrosis has occurred.
D000328:Adult; D003613:Danazol / Q000627:therapeutic use*; D004715:Endometriosis / Q000150:complications* / Q000188:drug therapy; D005260:Female; D006801:Humans; D011245:Pregnadienes / Q000627:therapeutic use*; D014516:Ureteral Neoplasms / Q000188:drug therapy*; D014517:Ureteral Obstruction / Q000209:etiology*
D011245:Pregnadienes; D003613:Danazol